Sphingolipid-mediated inhibition of apoptotic cell clearance by alveolar macrophages

Daniela N Petrusca1, Yuan Gu, Jeremy J Adamowicz

  • 1Department of Medicine, Indiana University, Indianapolis, Indiana 46202, USA.

Insights

High ceramide levels in the lungs impair the ability of alveolar macrophages to clear apoptotic cells, a process crucial for preventing emphysema inflammation. This ceramide-induced defect is linked to cigarette smoke exposure and involves sphingosine production.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Biochemistry

Background:

  • Decreased clearance of apoptotic cells (efferocytosis) by alveolar macrophages (AM) is implicated in emphysema pathogenesis.
  • Cigarette smoking (CS) increases lung ceramides, potentially contributing to AM dysfunction and cell death accumulation.

Purpose of the Study:

  • To investigate the hypothesis that ceramides inhibit AM efferocytosis.
  • To elucidate the mechanism by which ceramides impair efferocytosis and its relevance to CS-induced lung injury.

Main Methods:

  • Primary rat and human AM were treated with endogenous or exogenous ceramides to assess phagocytosis of apoptotic Jurkat cells.
  • In vivo studies involved intratracheal ceramide instillation in rats to evaluate efferocytosis of apoptotic thymocytes.
  • Mechanistic studies examined the role of sphingosine and Rac1 signaling in ceramide-mediated efferocytosis impairment.

Main Results:

  • Ceramide treatment, regardless of molecular species, dose-dependently impaired AM efferocytosis.
  • In vivo ceramide elevation significantly reduced apoptotic cell clearance by resident AM.
  • Ceramide-induced efferocytosis inhibition was dependent on sphingosine generation and impaired Rac1 recruitment, which could be rescued by Rac1 activation.
  • CS exposure increased AM ceramides, inhibited Rac1 recruitment, and profoundly impaired AM efferocytosis via sphingosine production.

Conclusions:

  • Excessive lung ceramides, exacerbated by CS, impair AM efferocytosis through sphingosine generation and disruption of Rac1 signaling.
  • This impaired efferocytosis may amplify lung injury in emphysema by promoting cell apoptosis and hindering clearance.
  • Targeting ceramide metabolism could be a therapeutic strategy for emphysema.

Related Concept Videos

Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...